LifeMD generated $46.87M in Q4 revenue, up 4% year-over-year, while gross margin expanded significantly to 87%. The company reported net income of $19.94M largely driven by discontinued operations related to the WorkSimpli sale, while the core telehealth business continued scaling with subscriber growth.

LifeMD delivered a solid Q3 with 13% revenue growth, improved adjusted EBITDA, and a significant reduction in net loss. The company strengthened its balance sheet by paying off all debt and exited its WorkSimpli stake to focus on core telehealth operations.

LifeMD achieved an outstanding first quarter, with total revenues increasing 49% year-over-year to $65.7 million and telehealth revenue up 70%. The company reported its first-ever quarter of positive GAAP net income of $0.6 million, or $0.01 per diluted share, and significantly raised its full-year 2025 guidance.

LifeMD achieved record quarterly revenue and adjusted EBITDA in Q4 2024, with consolidated revenue increasing 43% year-over-year to $64.3 million and adjusted EBITDA increasing 78% to $9.0 million. The telehealth segment was a key driver, with revenue up 60% and adjusted EBITDA up 396%.

LifeMD reported a 323% increase in revenue to $18.2 million for Q1 2021. The company also raised its full-year revenue guidance to $90-$100 million, reflecting strong growth and recurring subscription revenue.

LifeMD reported a significant increase in revenue for Q4 2020, reaching a record $12.9 million, a 227% increase compared to the same period last year. This growth was primarily driven by a substantial increase in telemedicine product revenues. The company is forecasting revenue to range between $85 million and $95 million for the full year 2021.